Formulation and characterization of tobramycin-chitosan nanoparticles coated with zinc oxide nanoparticles

Herein we describe the preparation, characterization and the antibacterial effect of Tobramycin-chitosan nanoparticles (TOB-CS NPs) coated with zinc oxide nanoparticles (ZnO NPs). Four formulations of TOB-CS NPs (A-D) were prepared to study the effect of experimental variables on the NPs behavior. T...

Full description

Bibliographic Details
Main Authors: Nusaiba.K. Al-nemrawi, Rami Q. Alkhatib, Hadeel Ayyad, Nid''A Alshraiedeh
Format: Article
Language:English
Published: Elsevier 2022-04-01
Series:Saudi Pharmaceutical Journal
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S1319016422000238
_version_ 1818149835056873472
author Nusaiba.K. Al-nemrawi
Rami Q. Alkhatib
Hadeel Ayyad
Nid''A Alshraiedeh
author_facet Nusaiba.K. Al-nemrawi
Rami Q. Alkhatib
Hadeel Ayyad
Nid''A Alshraiedeh
author_sort Nusaiba.K. Al-nemrawi
collection DOAJ
description Herein we describe the preparation, characterization and the antibacterial effect of Tobramycin-chitosan nanoparticles (TOB-CS NPs) coated with zinc oxide nanoparticles (ZnO NPs). Four formulations of TOB-CS NPs (A-D) were prepared to study the effect of experimental variables on the NPs behavior. Two formulations of ZnO NPs were prepared using the solvothermal and the precipitation methods (ZnO1 and ZnO2), and then characterized. TOB-CS NPs (Formula d) was coated with the ZnO1. Moreover, the antibacterial activity of TOB-CS NPs, ZnO NPs and the coated nanoparticles against S. aureus and E. coli was examined. Changing the variables in preparing TOB-CS NPs resulting in variabilities in sizes (297.6–1116.3 nm), charges (+8.29–+39.00 mV), entrapment (51.95–90.60%). Further, TOB release was sustained over four days. ZnO NPs have sizes of 47.44 and 394.4 nm and charges of −62.3 and 89.4 mV when prepared by solvothermal and precipitation technique, respectively. Coated TOB-CS NPs had a size of 342 nm, a charge of +4.39 and released 100 µg/ mL of the drug after four days. The antimicrobial activity of TOB-CS NPs was lower than free TOB against S. aureus and E. coli. The coated NPs showed higher antimicrobial effect in comparison to formula D and ZnO1. In conclusion, coating TOB-CS NPs with ZnO NPs exhibited a great antibacterial effect that may be sustained for days.
first_indexed 2024-12-11T13:13:21Z
format Article
id doaj.art-cabbbb04d01740f284763d5b45022bb5
institution Directory Open Access Journal
issn 1319-0164
language English
last_indexed 2024-12-11T13:13:21Z
publishDate 2022-04-01
publisher Elsevier
record_format Article
series Saudi Pharmaceutical Journal
spelling doaj.art-cabbbb04d01740f284763d5b45022bb52022-12-22T01:06:07ZengElsevierSaudi Pharmaceutical Journal1319-01642022-04-01304454461Formulation and characterization of tobramycin-chitosan nanoparticles coated with zinc oxide nanoparticlesNusaiba.K. Al-nemrawi0Rami Q. Alkhatib1Hadeel Ayyad2Nid''A Alshraiedeh3Department of Pharmaceutical Technology, Faculty of Pharmacy, Jordan University of Science and Technology, Jordan; Corresponding author.Department of Biotechnology and Genetic Engineering, Faculty of Science and Art, Jordan University of Science and Technology, JordanDepartment of Applied Biological Sciences, Faculty of Science and Art, Jordan University of Science and Technology, JordanDepartment of Pharmaceutical Technology, Faculty of Pharmacy, Jordan University of Science and Technology, JordanHerein we describe the preparation, characterization and the antibacterial effect of Tobramycin-chitosan nanoparticles (TOB-CS NPs) coated with zinc oxide nanoparticles (ZnO NPs). Four formulations of TOB-CS NPs (A-D) were prepared to study the effect of experimental variables on the NPs behavior. Two formulations of ZnO NPs were prepared using the solvothermal and the precipitation methods (ZnO1 and ZnO2), and then characterized. TOB-CS NPs (Formula d) was coated with the ZnO1. Moreover, the antibacterial activity of TOB-CS NPs, ZnO NPs and the coated nanoparticles against S. aureus and E. coli was examined. Changing the variables in preparing TOB-CS NPs resulting in variabilities in sizes (297.6–1116.3 nm), charges (+8.29–+39.00 mV), entrapment (51.95–90.60%). Further, TOB release was sustained over four days. ZnO NPs have sizes of 47.44 and 394.4 nm and charges of −62.3 and 89.4 mV when prepared by solvothermal and precipitation technique, respectively. Coated TOB-CS NPs had a size of 342 nm, a charge of +4.39 and released 100 µg/ mL of the drug after four days. The antimicrobial activity of TOB-CS NPs was lower than free TOB against S. aureus and E. coli. The coated NPs showed higher antimicrobial effect in comparison to formula D and ZnO1. In conclusion, coating TOB-CS NPs with ZnO NPs exhibited a great antibacterial effect that may be sustained for days.http://www.sciencedirect.com/science/article/pii/S1319016422000238TobramycinNanoparticlesIonic gelationTPPZinc oxideBacterial resistance
spellingShingle Nusaiba.K. Al-nemrawi
Rami Q. Alkhatib
Hadeel Ayyad
Nid''A Alshraiedeh
Formulation and characterization of tobramycin-chitosan nanoparticles coated with zinc oxide nanoparticles
Saudi Pharmaceutical Journal
Tobramycin
Nanoparticles
Ionic gelation
TPP
Zinc oxide
Bacterial resistance
title Formulation and characterization of tobramycin-chitosan nanoparticles coated with zinc oxide nanoparticles
title_full Formulation and characterization of tobramycin-chitosan nanoparticles coated with zinc oxide nanoparticles
title_fullStr Formulation and characterization of tobramycin-chitosan nanoparticles coated with zinc oxide nanoparticles
title_full_unstemmed Formulation and characterization of tobramycin-chitosan nanoparticles coated with zinc oxide nanoparticles
title_short Formulation and characterization of tobramycin-chitosan nanoparticles coated with zinc oxide nanoparticles
title_sort formulation and characterization of tobramycin chitosan nanoparticles coated with zinc oxide nanoparticles
topic Tobramycin
Nanoparticles
Ionic gelation
TPP
Zinc oxide
Bacterial resistance
url http://www.sciencedirect.com/science/article/pii/S1319016422000238
work_keys_str_mv AT nusaibakalnemrawi formulationandcharacterizationoftobramycinchitosannanoparticlescoatedwithzincoxidenanoparticles
AT ramiqalkhatib formulationandcharacterizationoftobramycinchitosannanoparticlescoatedwithzincoxidenanoparticles
AT hadeelayyad formulationandcharacterizationoftobramycinchitosannanoparticlescoatedwithzincoxidenanoparticles
AT nidaalshraiedeh formulationandcharacterizationoftobramycinchitosannanoparticlescoatedwithzincoxidenanoparticles